Pyxis Oncology, Inc. — Director's Dealing 2023

Sep 23, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pyxis Oncology, Inc. (PYXS)
CIK: 0001782223
Period of Report: 2023-09-22

Reporting Person: Connealy Pamela Ann (CFO and COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-09-22	Common Stock	P	5000	$1.739	Acquired	792106	Direct

Footnotes

F1: The Reporting Person purchased all 5,000 shares of common stock in the open market at a price of $1.739 per share.